SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Brera Holdings PLC

(Name of Issuer)

Class B Ordinary Shares, $0.05 nominal value per share

(Title of Class of Securities)

G13311116

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

G13311116

Names of Reporting Persons

Qube Research & Technologies Ltd

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,529,638.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,529,638.00

Aggregate Amount Beneficially Owned by Each Reporting Person

6,529,638.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

9.8 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

G13311116

Names of Reporting Persons

Pierre-Yves Morlat

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,529,638.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,529,638.00

Aggregate Amount Beneficially Owned by Each Reporting Person

6,529,638.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

9.8 %

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Brera Holdings PLC

(b)

Address of issuer's principal executive offices:

CONNAUGHT HOUSE, 5TH FLOOR, ONE BURLINGTON ROAD, DUBLIN 4, IRELAND, D04 C5Y6.

Item 2.

(a)

Name of person filing:

This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): i. Qube Research & Technologies Limited ("QRT"); and ii. Pierre-Yves Morlat ("Mr. Morlat"). This Statement relates to Class B Ordinary Shares ("Shares") held for the accounts of QRT Master Fund SPC - Torus Fund SP and Qube Master Fund Ltd. (collectively, the "QRT Funds") QRT serves as investment manager to each of the QRT Funds. Mr. Morlat is the Chief Executive Officer of QRT.

(b)

Address or principal business office or, if none, residence:

9 Bressenden Place, London, SW1E 5BY, United Kingdom

(c)

Citizenship:

United Kingdom, France

(d)

Title of class of securities:

Class B Ordinary Shares, $0.05 nominal value per share

(e)

CUSIP No.:

G13311116

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Investment Adviser

Item 4.

Ownership

(a)

Amount beneficially owned:

6,529,638

(b)

Percent of class:

9.8 %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

(ii) Shared power to vote or to direct the vote:

6,529,638

(iii) Sole power to dispose or to direct the disposition of:

(iv) Shared power to dispose or to direct the disposition of:

6,529,638

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

Certain investment vehicles managed by [QRT][Qube Research & Technologies Limited], including QRT Master Fund SPC - Torus Fund SP, are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

The response to Item 2 is incorporated by reference herein.

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Qube Research & Technologies Limited as an investment manager registered with the Financial Conduct Authority of the United Kingdom is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Qube Research & Technologies Ltd

Signature:	/s/ Claire Jarrett
Name/Title:	Chief Compliance Officer
Date:	11/14/2025

Pierre-Yves Morlat

Signature:	/s/ Pierre-Yves Morlat
Name/Title:	Chief Executive Officer
Date:	11/14/2025

Exhibit Information

Exhibit 1: Joint Filing Agreement